T-cell subsets, T-cell receptor repertoire and HIV-1 virological reservoir in children initiating first-line dolutegravir versus standard-of-care ART: results from the ODYSSEY trial

26 Jul, 2026

Authors: Gärtner K, Wyncoll J, Hammer ASB, Rattenborg MN, Adams S, Byott M, Alber D, Botha JC, Kekitiinwa AR, Kityo C, Bamford A, Bwakura-Dangarembizi M, Violari A, Ounchanum P, Lugemwa A, Rojo P, Giaquinto C, Gibb D, Ford D, Turkova A, Sandgaard KS, Nastouli E; ODYSSEY trial team.

Presented at: International Workshop on Pediatrics and HIV